1. Home
  2. KIDZ vs AGEN Comparison

KIDZ vs AGEN Comparison

Compare KIDZ & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIDZ
  • AGEN
  • Stock Information
  • Founded
  • KIDZ 2020
  • AGEN 1994
  • Country
  • KIDZ United States
  • AGEN United States
  • Employees
  • KIDZ N/A
  • AGEN N/A
  • Industry
  • KIDZ
  • AGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KIDZ
  • AGEN Health Care
  • Exchange
  • KIDZ NYSE
  • AGEN Nasdaq
  • Market Cap
  • KIDZ 75.4M
  • AGEN 87.7M
  • IPO Year
  • KIDZ N/A
  • AGEN 2000
  • Fundamental
  • Price
  • KIDZ $1.64
  • AGEN $5.88
  • Analyst Decision
  • KIDZ
  • AGEN Strong Buy
  • Analyst Count
  • KIDZ 0
  • AGEN 3
  • Target Price
  • KIDZ N/A
  • AGEN $16.33
  • AVG Volume (30 Days)
  • KIDZ 1.2M
  • AGEN 1.4M
  • Earning Date
  • KIDZ 01-01-0001
  • AGEN 08-07-2025
  • Dividend Yield
  • KIDZ N/A
  • AGEN N/A
  • EPS Growth
  • KIDZ N/A
  • AGEN N/A
  • EPS
  • KIDZ N/A
  • AGEN N/A
  • Revenue
  • KIDZ N/A
  • AGEN $99,524,000.00
  • Revenue This Year
  • KIDZ N/A
  • AGEN $25.31
  • Revenue Next Year
  • KIDZ N/A
  • AGEN N/A
  • P/E Ratio
  • KIDZ N/A
  • AGEN N/A
  • Revenue Growth
  • KIDZ N/A
  • AGEN N/A
  • 52 Week Low
  • KIDZ $1.03
  • AGEN $1.38
  • 52 Week High
  • KIDZ $10.65
  • AGEN $7.34
  • Technical
  • Relative Strength Index (RSI)
  • KIDZ N/A
  • AGEN 52.07
  • Support Level
  • KIDZ N/A
  • AGEN $5.81
  • Resistance Level
  • KIDZ N/A
  • AGEN $6.58
  • Average True Range (ATR)
  • KIDZ 0.00
  • AGEN 0.62
  • MACD
  • KIDZ 0.00
  • AGEN -0.08
  • Stochastic Oscillator
  • KIDZ 0.00
  • AGEN 35.68

About KIDZ CLASSOVER HLDGS INC

Classover Holdings Inc is an education technology company based in New York. It provides comprehensive online interactive live courses for K-12 students in the United States and around the globe. Its curriculum is designed to meet the needs of different age groups and learning levels, covering various subjects to enhance students' academic achievements and interest in exploration. The company offers both interest-oriented classes and test preparation courses for various exams and competitions. With its approach, Classover aims to transcend the boundaries of traditional education by offering students a comprehensive set of lifelong skills and capabilities, including creativity, critical thinking, and problem-solving, in an engaging and interactive environment.

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

Share on Social Networks: